Northern Trust’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Northern Trust's RXRX Position: Q3 2026 in Review
Northern Trust increased its Recursion Pharmaceuticals (RXRX) stake by 1.3% in Q3 2026, buying an estimated $217K and bringing the position to 4,822,366 shares worth $19.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1749.
Northern Trust first reported a position in RXRX in Q2 2021 and has held it in 22 quarters since. 347 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Northern Trust held 4,822,366 shares of Recursion Pharmaceuticals worth $19.9M as of Q3 2026.
- Northern Trust bought 64,130 Recursion Pharmaceuticals shares in Q3 2026, an estimated $217K.
- Recursion Pharmaceuticals made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #1749 holding.
- Northern Trust first reported a position in Recursion Pharmaceuticals in Q2 2021 and has held it in 22 quarters since.
- 347 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.